UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 301

Sortiert nach

Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients

Journal of antimicrobial chemotherapy, 2011-02, Vol.66 (2), p.227-231

2011

Volltextzugriff (PDF)

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

Journal of antimicrobial chemotherapy, 2009-07, Vol.64 (1), p.142-150

2009

Volltextzugriff (PDF)

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

Clinical gastroenterology and hepatology, 2014-12, Vol.12 (12), p.2092-2103.e6

2014

Volltextzugriff (PDF)

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

Journal of Neural Transmission, 2019-01, Vol.126 (1), p.5-18

2019

Volltextzugriff (PDF)

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

International journal of antimicrobial agents, 2010-02, Vol.35 (2), p.156-163

2010

Volltextzugriff (PDF)

Consistent terminology for medication-related problems in pharmacogenomic cases

Journal of psychiatry & neuroscience, 2023-05, Vol.48 (3), p.E151-E152

2023

Volltextzugriff (PDF)

New Horizons in the impact of frailty on pharmacokinetics: latest developments

Age and ageing, 2021-07, Vol.50 (4), p.1054-1063

2021

Volltextzugriff (PDF)

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Critical care (London, England), 2015-01, Vol.19 (1), p.28-28, Article 28

2015

Volltextzugriff (PDF)

The Relationship between Drug Clearance and Body Size: Systematic Review and Meta-Analysis of the Literature Published from 2000 to 2007

Clinical pharmacokinetics, 2012-05, Vol.51 (5), p.319-330

2012

Volltextzugriff (PDF)

Evaluation of a Situational Judgement Test to Develop Non-Academic Skills in Pharmacy Students

American journal of pharmaceutical education, 2019-12, Vol.83 (10), p.7074-2101, Article 7074

2019

Volltextzugriff (PDF)

Drug repurposing using real-world data

Drug discovery today, 2023-01, Vol.28 (1), p.103422-103422, Article 103422

2023

Volltextzugriff (PDF)

The dosing and monitoring of vancomycin: what is the best way forward?

International journal of antimicrobial agents, 2019-04, Vol.53 (4), p.401-407

2019

Volltextzugriff (PDF)

Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

Prevalence and Factors Associated With Polypharmacy in Long-Term Care Facilities: A Systematic Review

Journal of the American Medical Directors Association, 2015-06, Vol.16 (6), p.535.e1-535.e12

2015

Volltextzugriff (PDF)

Resveratrol – pills to replace a healthy diet?

British journal of clinical pharmacology, 2011-07, Vol.72 (1), p.27-38

2011

Volltextzugriff (PDF)

Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients

Antimicrobial agents and chemotherapy, 2019-12, Vol.64 (1)

2019

Volltextzugriff (PDF)

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.707-711

2021

Volltextzugriff (PDF)

A Time-to-Event Pharmacodynamic Model Describing Treatment Response in Patients with Pulmonary Tuberculosis Using Days to Positivity in Automated Liquid Mycobacterial Culture

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.789-795

2013

Volltextzugriff (PDF)

Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—A meta-analysis

Clinical biochemistry, 2007-03, Vol.40 (5), p.383-391

2007

Volltextzugriff (PDF)

Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions Between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort Study

Journal of the American Geriatrics Society (JAGS), 2016-01, Vol.64 (1), p.89-95

2016

Volltextzugriff (PDF)

A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy

Critical reviews in oncology/hematology, 2022-04, Vol.172, p.103606-103606, Article 103606

2022

Volltextzugriff (PDF)

Using Population Pharmacokinetics To Determine Gentamicin Dosing during Extended Daily Diafiltration in Critically Ill Patients with Acute Kidney Injury

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3635-3640

2010

Volltextzugriff (PDF)

Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile

Clinical cancer research, 2018-05, Vol.24 (10), p.2319-2327

2018

Volltextzugriff (PDF)

Model‐informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection

British journal of clinical pharmacology, 2021-09, Vol.87 (9), p.3388-3397

2021

Volltextzugriff (PDF)

Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling

Antimicrobial agents and chemotherapy, 2018-05, Vol.62 (5)

2018

Volltextzugriff (PDF)

1 – 25 von 301

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(260)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(236)
Life Sciences & Biomedicine
(227)
Humans
(171)
Pharmacology & Pharmacy
(123)
Male
(87)
Female
(81)
Biological And Medical Sciences
(69)
Medical Sciences
(63)
Adult
(57)
Pharmacology. Drug Treatments
(51)
Middle Aged
(45)
Aged
(44)
Microbiology
(42)
Pharmacokinetics
(41)
Infectious Diseases
(40)
Pharmacology
(33)
Animals
(27)
Anti-Bacterial Agents - Pharmacokinetics
(27)
Medicine
(26)
Surgery
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patients

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

Consistent terminology for medication-related problems in pharmacogenomic cases

New Horizons in the impact of frailty on pharmacokinetics: latest developments

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

The Relationship between Drug Clearance and Body Size: Systematic Review and Meta-Analysis of the Literature Published from 2000 to 2007

Evaluation of a Situational Judgement Test to Develop Non-Academic Skills in Pharmacy Students

Drug repurposing using real-world data

The dosing and monitoring of vancomycin: what is the best way forward?

Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model

Prevalence and Factors Associated With Polypharmacy in Long-Term Care Facilities: A Systematic Review

Resveratrol – pills to replace a healthy diet?

Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients

A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID‐19 (SARS‐COV‐2) treatments

A Time-to-Event Pharmacodynamic Model Describing Treatment Response in Patients with Pulmonary Tuberculosis Using Days to Positivity in Automated Liquid Mycobacterial Culture

Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—A meta-analysis

Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions Between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort Study

A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy

Using Population Pharmacokinetics To Determine Gentamicin Dosing during Extended Daily Diafiltration in Critically Ill Patients with Acute Kidney Injury

Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile

Model‐informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospection

Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling

Suchergebnisse filtern